ULTRAGENYX PHARMACEUTICAL INC. Long-term Investments
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Long-term Investments of $4.07 million as of 2020-06-30, per its 10-Q filed 2020-07-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:LongTermInvestments · last filed 2020-10-27
- 2020-06-30: Long-term Investments $4.07M.
- 2020-03-31: Long-term Investments $41.71M.
- 2019-12-31: Long-term Investments $5.17M.
- 2018-03-31: Long-term Investments $29.91M.
| Period end | Long-term Investments |
|---|---|
| 2020-06-30 | $4.07M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $41.71M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.17M 10-Q · filed 2020-10-27 |
| 2018-03-31 | $29.91M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $9.97M 10-K · filed 2019-02-20 |
| 2017-09-30 | $24.96M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $57.80M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $80.86M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $117.96M 10-K · filed 2018-02-21 |
| 2016-09-30 | $76.21M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $50.02M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $75.93M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $99.26M 10-K · filed 2017-02-17 |
| 2015-09-30 | $133.49M 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |